Special Meeting Scheduled for June 29, 2021BOSTON (BUSINESS WIRE) Therapeutics Acquisition Corp, d/b/a Research Alliance Corp. I, a Delaware corporation (“the Company”) (Nasdaq: RACA) announced today that its registration statement on Form S-4 (File Number 333-254600) (as amended, the “Registration Statement”), re.
INDIANAPOLIS, June 04, 2021 (GLOBE NEWSWIRE) POINT Biopharma Inc. (POINT), a global radiopharmaceutical company dedicated to successfully delivering precision radioligand therapy to cancer patients
Replacing press release issued April 28, 2021 to correct ticker to RACA.Globally focused radiopharmaceutical company achieves significant milestone to accelerate the operationalization of their 80,000 sq ft radioligand manufacturing facilityINDIANAPOLIS (BUSINESS WIRE) POINT Biopharma Inc. (POINT), a radiopharmace.